Summarize Kasr al Ainy
Benjamin Gravesteijn
31-12-2021
Summary
| Internal Medicine | Ophtalmology | Surgery | Pediatrics | Gynaecology | Dermatology | Urology | Neuropsychiatry | Radiology | Public health | Anesthesia | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| n | 192 | 68 | 49 | 45 | 49 | 34 | 26 | 30 | 23 | 12 | 12 |
| Publication.Year (mean (SD)) | 2018.06 (2.49) | 2018.79 (1.99) | 2017.84 (2.77) | 2017.76 (2.85) | 2017.65 (3.92) | 2018.06 (2.59) | 2017.85 (3.29) | 2019.50 (1.98) | 2016.91 (3.79) | 2018.92 (1.62) | 2018.00 (1.60) |
| Study.type (%) | |||||||||||
| Observational | 94 (49.0) | 19 (28.4) | 26 (53.1) | 26 (57.8) | 15 (30.6) | 6 (17.6) | 13 (50.0) | 11 (36.7) | 9 (39.1) | 9 (75.0) | 1 ( 8.3) |
| Review | 19 ( 9.9) | 4 ( 6.0) | 6 (12.2) | 5 (11.1) | 5 (10.2) | 1 ( 2.9) | 1 ( 3.8) | 4 (13.3) | 4 (17.4) | 2 (16.7) | 1 ( 8.3) |
| Randomized controlled trial | 7 ( 3.6) | 11 (16.4) | 4 ( 8.2) | 3 ( 6.7) | 8 (16.3) | 10 (29.4) | 5 (19.2) | 1 ( 3.3) | 0 ( 0.0) | 0 ( 0.0) | 7 (58.3) |
| Non-randomized trial | 14 ( 7.3) | 10 (14.9) | 7 (14.3) | 4 ( 8.9) | 6 (12.2) | 5 (14.7) | 3 (11.5) | 0 ( 0.0) | 4 (17.4) | 0 ( 0.0) | 0 ( 0.0) |
| Laboratory | 24 (12.5) | 2 ( 3.0) | 2 ( 4.1) | 0 ( 0.0) | 0 ( 0.0) | 2 ( 5.9) | 0 ( 0.0) | 6 (20.0) | 1 ( 4.3) | 0 ( 0.0) | 0 ( 0.0) |
| Case report | 14 ( 7.3) | 13 (19.4) | 3 ( 6.1) | 2 ( 4.4) | 2 ( 4.1) | 3 ( 8.8) | 1 ( 3.8) | 2 ( 6.7) | 5 (21.7) | 0 ( 0.0) | 3 (25.0) |
| Case control | 18 ( 9.4) | 5 ( 7.5) | 0 ( 0.0) | 5 (11.1) | 3 ( 6.1) | 6 (17.6) | 3 (11.5) | 6 (20.0) | 0 ( 0.0) | 1 ( 8.3) | 0 ( 0.0) |
| Systematic review | 2 ( 1.0) | 3 ( 4.5) | 1 ( 2.0) | 0 ( 0.0) | 10 (20.4) | 1 ( 2.9) | 0 ( 0.0) | 0 ( 0.0) | 0 ( 0.0) | 0 ( 0.0) | 0 ( 0.0) |